Danforth Advisors

Biography

Daniel Geffken is a Founder and Managing Director of Danforth Advisors. Daniel brings more than 22 years of experience in the life science industry to his work with Danforth Advisors clients, ranging from early start-ups to publicly traded companies with $1 billion+ market capitalizations. Previously, he has served as COO or CFO of four publicly traded and four privately held companies, in addition to his consulting clients, and was interim CEO of a medical device company. In these roles, he has had management responsibility for finance, accounting, human resources, investor/public relations, facilities, legal, intellectual property, and manufacturing functions. Daniel has assisted in raising more than $1 billion in equity and debt securities. He serves on the Board of Directors for Alcobra, a biopharmaceutical company that completed an initial public offering in May 2013. He has a BS in Economics from The Wharton School, University of Pennsylvania and an MBA from Harvard Business School.

Research Interest

In these roles, he has had management responsibility for finance, accounting, human resources, investor/public relations, facilities, legal, intellectual property, and manufacturing functions. Daniel has assisted in raising more than $1 billion in equity and debt securities. He serves on the Board of Directors for Alcobra, a biopharmaceutical company that completed an initial public offering in May 2013. He has a BS in Economics from The Wharton School, University of Pennsylvania and an MBA from Harvard Business School.